Table 2.
The Laboratory indexes of the patients in the study cohort
| Variables | 100-days outcome | ||||
|---|---|---|---|---|---|
|
| |||||
| All | Death | Survive | t/Z | p-value | |
| Laboratory index | |||||
| T (°C) | 39 (0.8) | 38.8 (0.8) | 39.1 (0.7) | −0.155 | 0.877 |
| MAP (mmHg) | 80±20 | 57 (16) | 83 (23) | −8.960 | 0.000 |
| HR (bpm) | 102 (31) | 119±28 | 100 (30) | −5.960 | 0.000 |
| RR (bpm) | 22 (11) | 25 (9) | 20 (9) | −6.293 | 0.000 |
| PCT (ng/mL) | 4.1 (12.0) | 4.4 (10.6) | 3.1 (12.1) | −1.665 | 0.096 |
| CRP (mmol/L) | 97.3 (82.5) | 120.1 (93.5) | 89.1 (82.2) | −3.163 | 0.002 |
| WBC (×109/L) | 12.0 (11.1) | 11.2 (12.9) | 13.2 (12.5) | −0.634 | 0.526 |
| Hb (g/L) | 116.6±28.1 | 112.9±32.9 | 117.8±26.3 | 1.840 | 0.078 |
| HCT (%) | 34.0±11.4 | 33.8±9.3 | 34.0 (11.3) | −1.546 | 0.122 |
| Plt (×109/L) | 181.0 (108.5) | 165.0 (108.0) | 181.5 (120.8) | −2.781 | 0.005 |
| N% | 90.2 (7.1) | 91.1 (4.9) | 90.3 (9.1) | −0.270 | 0.788 |
| FIB (g/L) | 454.5±185.5 | 437.0±184.8 | 460.2±186.8 | −0.064 | 0.955 |
| D-D (mg/L) | 4.70 (12.0) | 9.23 (14.2) | 4.53 (9.3) | −4.471 | 0.000 |
| BNP (pg/mL) | 2082 (4502) | 3184 (1190) | 1450 (3966) | −3.994 | 0.000 |
| cTn I (ng/mL) | 0.04 (0.16) | 0.9 (0.68) | 0.03 (0.08) | −5.789 | 0.000 |
| ALT (U/L) | 18 (24) | 19 (18) | 18 (25) | −0.309 | 0.757 |
| AST (U/L) | 28 (43) | 29 (33) | 27 (48) | −1.320 | 0.187 |
| ALB (g/L) | 34.1±7.9 | 29.9±3.9 | 35.5±5.3 | 7.697 | 0.000 |
| TBIL () | 16.1 (13.7) | 13.5 (14.8) | 17.1 (13.9) | −0.072 | 0.942 |
| GLU (mmol/L) | 8.4 (5.2) | 8.3 (6.1) | 8.4 (3.9) | −0.116 | 0.908 |
| UREA (mmol/L) | 9.4 (5.3) | 12.6 (11.4) | 8.1 (5.2) | −5.140 | 0.000 |
| CREA (μm/L) | 84.1 (49.3) | 122.2 (288.5) | 84.4 (49.0) | −1.982 | 0.047 |
| Ca (mmol/L) | 2.1 (0.2) | 2.1±0.2 | 2.1 (0.2) | −4.232 | 0.000 |
| K (mmol/L) | 4.0 (0.7) | 4.0±0.7 | 3.9±0.5 | −1.994 | 0.048 |
| Na (mmol/L) | 135 (8) | 136 (13) | 135 (7) | −1.447 | 0.148 |
| PH | 7.42 (0) | 7.39 (0) | 7.44 (0) | −3.180 | 0.001 |
| PO2 (mmHg) | 77.2 (42.6) | 90.1 (57.3) | 76.1 (33.1) | −0.914 | 0.361 |
| LA (mmol/L) | 2.0 (2.5) | 2.6 (3.4) | 1.7 (2.2) | −2.461 | 0.014 |
| N (×109/L) | 10.8 (10.9) | 10.5 (11.4) | 11.2 (10.6) | −0.909 | 0.363 |
| L (×109/L) | 0.7 (0.8) | 13.2 (1.9) | 0.8 (0.9) | −0.955 | 0.340 |
| RDW-cv (%) | 13.7 (1.6) | 14.1 (0.7) | 13.2 (1.9) | −2.988 | 0.003 |
| NLR (%) | 13.5 (17.8) | 23.1 (47.7) | 12.2 (16.4) | −1.467 | 0.142 |
| PLR (%) | 251.7 (352.4) | 296.3 (261.7) | 205.1 (224.1) | −0.215 | 0.830 |
NOTE: T: temperature; MAP: mean arterial pressure; HR: heart rate; RR: respiratory rate; PCT: procalcitonin; CRP: C-reactive protein; WBC: white blood cell; Hb: Hemoglobin; HCT: hematocrit; Plt: blood platelet; FIB: Fibrinogen; BNP: B-type natriuretic peptide; cTn I: I Cardiac troponin I; ALT: glutamate-pyruvate transaminase; AST: Glutamic-oxal(o)acetic transaminase; ALB: albumin; TBIL: total bilirubin; GLU: Blood glucose; CREA: creatinine; PO2: oxygen partial pressure; LA: Lactic acid; N: Absolute neutrophil count; L: Absolute lymphocyte count; RDW: Red Cell volume Distribution; NLR: neutrophil-lymphocyte ratio; PLR: platelet-lymphocyte ratio